Join us at the FTC!
Displaying 121 - 140 of 159
Remarks of Chair Lina M. Khan Regarding the 6(b) Study on Pharmacy Benefit Managers
Date
Matter Number
P221002
By
Lina M. Khan, Chair
File
Text of Statement
(195.96 KB)
Concurring Statement of Commissioner Slaughter and Chair Khan regarding FTC and State of Rhode Island v. Lifespan Corporation and Care New England Health System
Date
Matter Number
2110031
By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner
File
Concurring Statement of Commissioner Rebecca Kelly Slaughter, Joined by Chair Lina M. Khan, Regarding the 2022 Revised Clayton Act Thresholds
Date
Matter Number
P859910
By
Rebecca Kelly Slaughter, Commissioner;
Lina M. Khan, Chair
Remarks of Chair Lina M. Khan Regarding the Advance Notice of Proposed Rulemaking on Government & Business Impersonation
Date
Matter Number
R207000
By
Lina M. Khan, Chair
File
Text of Remarks
(128.03 KB)
Related Releases
Statement of Chair Lina M. Khan on Issuance of the Commission Statement Regarding the Criminal Referral and Partnership Process
Date
Matter Number
P094207
By
Lina M. Khan, Chair
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter Regarding the FY 2020 Hart-Scott-Rodino Annual Report for Transmittal to Congress
Date
Matter Number
P110014
By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter Regarding Regulatory Review of the Safeguards Rule
Date
Matter Number
P145407
By
Lina M. Khan, Chair;
Rebecca Kelly Slaughter, Commissioner
Remarks of Chair Lina M. Khan Regarding the 6(b) Study on the Privacy Practices of Six Major Internet Service Providers
Date
Matter Number
P195402
By
Lina M. Khan, Chair
File
Text of Remarks
(175.64 KB)
Statement of Chair Lina M. Khan Regarding the Report to Congress on Privacy and Security
Date
Matter Number
P065401
By
Lina M. Khan, Chair
Displaying 121 - 140 of 159